Entera Bio reported Q2 2024 revenue of $57.0K. Diluted EPS came in at $-0.06.
Trailing eight quarters through Q2 2024
Common questions about Entera Bio's Q2 2024 earnings report.
Entera Bio (ENTX) reported Q2 2024 earnings on August 9, 2024 before market open.
Entera Bio reported revenue of $57.0K and diluted EPS of $-0.06 for Q2 2024.
EPS beat the consensus estimate of $-0.06 by $0.00.
You can read the 10-Q periodic report (0001178913-24-002522) directly on SEC EDGAR. The filing index links above go to sec.gov.